Determination of interferon-α-producing capacity in whole blood cultures from patients with various diseases and from healthy persons

Journal of Interferon and Cytokine Research

Volumn 16, Issue 11, 1996, Pages 911-918

  Uno, Kazuko ^a   Nakano, Koji ^b   Maruo, Naoyuki ^a   Onodera, Hideki ^b   Mata, Hiroko ^a,b   Kurosu, Isao ^c   Akatani, Kaoru ^a   Ikegami, Nobuko ^d   Kishi, Atsuko ^a   Yasuda, Yuko ^a   Tanaka, Koji ^b   Setoguchi, Junnko ^a,b   Kondo, Motoharu ^b   Muramatsu, Shigeru ^e   Kishida, Tsunataro ^a  

^a Louis Pasteur Center for Medical Research   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c Hyogo Prefectural Rehabilitation Central Hospital   (Japan)

^d OSAKA NATIONAL HOSPITAL   (Japan)

^e KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

ADULT; AGED; ARTICLE; FEMALE; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; INTERFERON PRODUCTION; LUNG CANCER; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0029849255     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1996.16.911     Document Type: Article

References (41)

1. NORTH, M.E., SPICKETT, G.P., ALLSOP, J., WEBSTER, A.D., and FARRANT, J. (1989). Defective DNA synthesis by T cells in acquired common-variable hypogammaglobulinaemia on stimulation with mitogens. Clin. Exp. Immunol. 76, 19-23.
2. SCHLEIFER, S.J., KELLER, S.E., BOND, R.N., COHEN, J., and STEIN, M. (1989). Depressive disorder and immunity. Arch. Gen. Psychiatry 46, 81-87.
3. UCHIDA, A. (1986). The cytolytic and regulatory role of natural killer cells in human neoplasia. Biochim. Biophys. Acta 865, 329-340.
4. KIECOLT-GLASE, J.K., GLASER, R., STRAIN, E.C., STOUT, J.C., TARR, K.L., HOLLIDAY, J.E., and SPEICHER, C.E. (1986). Modulation of cellular immunity in medical students. J. Behav. Med. 9, 5-21.
5. KIRCHNER, H. (1986). The interferon system as an integral part of the defense system against infections. Antiviral Res. 6, 1-17.
6. NAKANE, A., and MINAGAWA, T. (1984). The significance of alpha/beta interferons and gamma interferon produced in mice infected with Listeria monocytogenes. Cell. Immunol. 88, 29-40.
7. REID, L.M., MINATO, N., GRESSER, I., HOLLAND, J., KADISH, A., and BLOOM, B.R. (1981). Influence of anti-mouse interferon serum on the growth and metastasis of tumor cells persistently infected with virus and human prostatic tumors in athymic nude mice. Proc. Natl. Acad. Sci. USA 78, 1171-1175.
8. ZAWATZKY, R., IFENHAUS, J.H., MARCUCCI, F., and KIRCHNER, H. (1983). Experimental infection of inbred mice with herpes simplex virus. I. Investigation of humoral and cellular immunity of interferon induction. J. Gen. Virol. 53, 31.
9. DE MAEYER, E., and DE MAEYER-GUIGNARD, J. (1969). Gene with quantitative effect on circulating interferon induced by Newcastle disease virus. J. Virol. 3, 506-512.
10. DE MAEYER, E., and DE MAEYER-GUIGNARD J. (1979). Considerations on mouse genes influencing interferon production and action. In: Interferon I. I. Gresser (ed.) New York: Academic Press, pp. 75-100.
11. DE MAEYER-GUIGNARD, J. (1972). Mouse leukemia: depression of serum interferon production. Science 177, 797-799.
12. LEE, S.H.S., OZERE, R.L., and ROOYEN, C.E. (1966). Interferon production by human leukocytes in vitro. Reduced levels in lymphatic leukemia. Proc. Soc. Exp. Biol. Med. 122, 32-39.
13. FERNANDEZ, R.C., LEE, S.H.S., FERNANDEZ, A.V., POPE, B.L., and ROZEE, K.R. (1986). Production of interferon by peripheral blood mononuclear cells from normal individuals and patients with chronic lymphocytic leukemia. J. Interferon Res. 6, 573-580.
14. IKEDA, T., LEVER, A.M.L., and THOMAS, H. (1986). Evidence for a deficiency of interferon production in patients with chronic hepatitis B virus infection acquired in adult life. Hepatology 6, 962-965.
15. ROSSOL, S., VOTH, H., LAUBENSTEIN, H.P., MULLER, W.E.G., SCHRODER, H.C., MEYER ZUM BUSCHENFELDE, K.H., and HESS, G. (1989). Interferon production in patients infected with HIV-1. J. Infect. Dis. 159, 815-821.
16. GENDELMAN, H.E., FRIEDMAN, R.M., JOE, S., BACA, L.M., TURPIN, J.A., DVEKSLER, G., MELTZER, M.S., and DIEFFENBACH, C. (1990). A selective defect of interferon α production in human immunodeficiency virus-infected monocytes. J. Exp. Med. 172, 1433-1442.
17. RUFFAULT, A., GENETET, N., BERTHIER, A.M., POMMEREUIL, M., DUVAIL, C., ANDRE, P. MOREL, H., GENETET, B., and FAUCONNIER, B. (1988). Interferon production in severe hemophiliacs with and without HIV antibodies. J. Interferon Res. 8, 89-94.
18. MIKULECKY, M. (1989). The issue of interferon-α production in hemophiliacs with HIV antibodies: a slight but significant decrease? J. Interferon Res. 9, 259-260.
19. KITA, M., SHIOZAWA, S., YAMAJI, M., KITO, I., and KISHIDA, T. (1991). Production of human-α and -γ interferon is dependent on age and sex and is decreased in rheumatoid arthritis: a simple method for large-scale assay. J. Clin. Lab. Anal. 5, 238-241.
20. KUO, J.Y., NISHIO, Y., KANAMARU, H., OKADA, Y., KITA, M., IMANISHI, J., KISHIDA, T., and YOSHIDA, O. (1991). Impaired interferon-α production in whole-blood cultures from bladder cancer patients. Urol. Res. 19, 51-56.
21. DOLDI, K., LEROUX, M., and AUGUSTIN, R. (1985). Proliferation and interferon production in whole blood samples and isolated lymphocyte preparations. J. Interferon Res. 5, 55-64.
22. KIRCHNER, H., KIEINICKE, C., and DIGEL, W. (1982). A whole-blood technique for testing production of human interferon by leukocytes. J. Immunol. Methods 48, 213-219.
23. BENNETT, J.M., CATOVSKY, D., DANIEL, M.T., FLANDRIN G., GALTON, D.A.G., GRANLNIK, H.R., and SULTAN, C. (1982). Proposals for the classification of myelodysplastic syndromes. Br. J. Haematol. 51, 189-199.
24. KOHASE, M., KOHNO, S., YAMAZAKI, S., SHISHIDO, A., and KONO, R. (1982). Potency Standardization of Human Interferon Preparations for Clinical Trials: The Clinical Potential of Interferons. No. 15, Japan Medical Foundation Publication, pp. 299-309.
25. SHIRONO, H., ITO, C., and KOGA, J. (1990). Studies on subtype composition in natural leukocyte interferon preparations. J. Virol. Methods 27, 1-10.
26. SOINI, E., and KOJOLA, H. (1983). Time-resolved fluorometer for lanthanide chelates - a new generation of nonisotopic immunoassays. Clin. Chem. 29, 65.
27. KATSCHINSKI, D.M., NEUSTOCK, P., KLUTER, H., and KIRCHNER, H. (1994). Influence of various factors on interferon-α production in cultures of human leukocytes. J. Interferon Res. 14, 105-110.
28. MARUO, N., UNO, K., TANAKA, K., YASUDA, Y., KISHI, A., FUKUDA, M., and KISHIDA, T. (1995). Diminished interferon-α-producing capacity in patients with refractory anemia with excess of blasts(RAEB). Hematol. Rev. 9, 191-195.
29. FOUCAR, K., LANGDON, R., II, ARMITAGE, J.O., OLSON, D.B., and CARROLL, T. Jr. (1985). Myelodysplastic syndromes: a clinical and pathologic analysis of 109 cases. Cancer 56, 553-561.
30. OGUMA, S., YOSHIDA, Y., UCHINO, H., OKUMA, M., MAEKAWA, T., and NOMURA, T. (1994). Infection in myelodys-plastic syndromes before evolution into acute non-lymphoblastic leukemia. Int. J. Hematol. 60, 129-136.
31. WILLMAN, C.L., SEVER, C.E., PALLAVICINI, M.G., HARADA, H., TANAKA, N., SLOVAK, M.L., YAMAMOTO, H., HARADA, K., MEEKER, T.C., LIST, A.F., and TANIGUCHI, T. (1993). Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodys-plasia. Science 259, 968-971.
32. BYBEE, J.D., and ROGERS, D.E. (1964). The phagocytic activity of polymorphonuclear leukocytes obtained from patients with diabetes mellitus. J. Lab. Clin. Med. 64, 1-13.
33. MOWAT, A.G., and BAUM, J. (1971). Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. N. Engl. J. Med. 284, 621-627.
34. DELESPESSE, G., DUCHATEAU, J., BASTENIE, P.A., LAURAUX, J.P., COLLET, H., and GOVAERTS, A. (1974). Cell-mediated immunity in diabetes mellitus. Clin. Exp. Immunol. 18, 461-467.
35. BAGDADE, J.D., STEWART, M., and WALTER, E. (1978). Impaired granulocyte adherence: a reversible defect in host defense in patients with poorly controlled diabetes. Diabetes 27, 677-681.
36. BONNEVIE-NIELSEN, V., LARSEN, M.L., FRIFELT, J.J., MICHELSEN, B., and LERNMARK, A. (1989). Association of IDDM and attenuated response of 2′,5′-olido-adenylate synthetase to yellow fever vaccine. Diabetes 38, 1636-1642.
37. YOSHIKAWA, M., YONEDA, T., MAEGAWA, J., TSUKAGUCHI, K., TOKUYAMA, T., FU, A., FUKUOKA, K., TOMODA, K., NAKAYA, M., FUKUOKA, A., YAMAMOTO, C., NARITA, N., ENOKI, Y., and MIKAMI, R. (1994). Relationship between nutritional depletion and cell-mediated immune function in acute pulmonary tuberculosis. Kekkaku 69, 307-316.
38. CHARDRA, R.K. (1983). Nutrition, immunity and infection: present knowledge and future directions. Lancet 26, 688-691.
39. SAKSELA, E., VIRTANEN, I., HOVI, T., SECHER, D., and CANTELL, K. (1983). Monocyte is the main producer of human alpha interferons following Sendai virus induction. Proc. Med. Virol. 30, 78.
40. GOBL, A.E., FUNA, K., and ALM, G.V. (1988). Different induction patterns of mRNA for IFN-α and -β in human mononuclear leukocytes after in vitro stimulation with herpes simplex virus-infected fibroblasts and Sendai virus. J. Immunol. 140, 3605-3609.
41. YAMAGUCHI, T., HANDA, K., SHIMIZU, Y., ABO, T., and KUMAGAI, K. (1977). Target cells for interferon production in human leukocytes stimulated by Sendai virus. J. Immunol. 118, 1931-1935.